Concepedia

Ayaka Ozaki

AO

Statistics

Publications

6

Citations

92

H-Index

6

Active since

2019

Affiliations

Tokyo University of Science(Current)

Tokyo University of Information Sciences

Juntendo University

Kanagawa Cancer Center

Kanagawa Prefectural Hospital Organization

Ayaka Ozaki is an author at Tokyo University of Science specializing in oncology, medicine, and molecular oncology.

Publications per year

2019–2022

6

Publications

6

High<i>SLC20A1</i>Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers

Chotaro Onaga, Shoma Tamori, Hitomi Motomura et al. · Anticancer Research · 2021 · 22 citations

, , +14

High Expression of<i>c-Met</i>,<i>PKCλ</i>and<i>ALDH1A3</i>Predicts a Poor Prognosis in Late-stage Breast Cancer

Hitomi Motomura, Yuka Nozaki, Chotaro Onaga et al. · Anticancer Research · 2019 · 19 citations · Full text

, , +17

High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients

Yuka Nozaki, Hitomi Motomura, Shoma Tamori et al. · PLoS ONE · 2020 · 14 citations · Full text

, , +17

Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late‑stage breast cancer

Hitomi Motomura, Ayaka Ozaki, Shoma Tamori et al. · Oncology Letters · 2021 · 13 citations · Full text

, , +12

GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival

Hitomi Motomura, Shoma Tamori, MASA-AKI YATANI et al. · Anticancer Research · 2021 · 12 citations · Full text

, , +17

1–5 of 6